Go Doc Go, Inc. – Trademark Portfolio

Entity Type: 03

Go Doc Go, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GO DOC GO and PREVENTING CERVICAL CANCER AROUND THE WORLD. The owner is based in New Paltz, NY.

1156 Old Ford Road

New Paltz, NY 12561

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Go Doc Go, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Go Doc Go, Inc. have?

Go Doc Go, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Go Doc Go, Inc. file in?

Go Doc Go, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What are Go Doc Go, Inc.'s most well-known trademarks?

Go Doc Go, Inc.'s registered trademark portfolio includes well-known marks such as GO DOC GO and PREVENTING CERVICAL CANCER AROUND THE WORLD. These are among 2 currently registered trademarks in the portfolio.

What is Go Doc Go, Inc.'s trademark registration success rate?

Go Doc Go, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.